BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7779812)

  • 1. Inhibition of nuclear protein binding to two sites in the murine c-myc promoter by intermolecular triplex formation.
    Reddoch JF; Miller DM
    Biochemistry; 1995 Jun; 34(23):7659-67. PubMed ID: 7779812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter.
    Kim HG; Miller DM
    Biochemistry; 1995 Jun; 34(25):8165-71. PubMed ID: 7794930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of c-myc transcription by triple helix formation.
    Postel EH
    Ann N Y Acad Sci; 1992 Oct; 660():57-63. PubMed ID: 1340156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex.
    Kim HG; Reddoch JF; Mayfield C; Ebbinghaus S; Vigneswaran N; Thomas S; Jones DE; Miller DM
    Biochemistry; 1998 Feb; 37(8):2299-304. PubMed ID: 9485376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
    Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
    Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triplex formation inhibits HER-2/neu transcription in vitro.
    Ebbinghaus SW; Gee JE; Rodu B; Mayfield CA; Sanders G; Miller DM
    J Clin Invest; 1993 Nov; 92(5):2433-9. PubMed ID: 7901237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of nuclear protein binding to the human Ki-ras promoter by triplex-forming oligonucleotides.
    Mayfield C; Squibb M; Miller D
    Biochemistry; 1994 Mar; 33(11):3358-63. PubMed ID: 8136373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra- and intermolecular triplex DNA formation in the murine c-myb proto-oncogene promoter are inhibited by mithramycin.
    Vigneswaran N; Thayaparan J; Knops J; Trent J; Potaman V; Miller DM; Zacharias W
    Biol Chem; 2001 Feb; 382(2):329-42. PubMed ID: 11308031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triplex formation prevents Sp1 binding to the dihydrofolate reductase promoter.
    Gee JE; Blume S; Snyder RC; Ray R; Miller DM
    J Biol Chem; 1992 Jun; 267(16):11163-7. PubMed ID: 1597451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters.
    DesJardins E; Hay N
    Mol Cell Biol; 1993 Sep; 13(9):5710-24. PubMed ID: 8355712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a novel triple helix-forming oligodeoxyribonucleotide directed to the major promoter of the c-myc gene.
    McGuffie EM; Catapano CV
    Nucleic Acids Res; 2002 Jun; 30(12):2701-9. PubMed ID: 12060688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three distinct elements within the murine c-myc promoter are required for transcription.
    Moberg KH; Logan TJ; Tyndall WA; Hall DJ
    Oncogene; 1992 Mar; 7(3):411-21. PubMed ID: 1549358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-fos protooncogene transcription can be modulated by oligonucleotide-mediated formation of triplex structures in vitro.
    Lavrovsky Y; Stoltz RA; Vlassov VV; Abraham NG
    Eur J Biochem; 1996 Jun; 238(2):582-90. PubMed ID: 8681975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of GC and AT specific DNA minor groove binding drugs on intermolecular triplex formation in the human c-Ki-ras promoter.
    Vigneswaran N; Mayfield CA; Rodu B; James R; Kim HG; Miller DM
    Biochemistry; 1996 Jan; 35(4):1106-14. PubMed ID: 8573565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells.
    Kim HG; Miller DM
    Biochemistry; 1998 Feb; 37(8):2666-72. PubMed ID: 9485417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat alpha1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts.
    Joseph J; Kandala JC; Veerapanane D; Weber KT; Guntaka RV
    Nucleic Acids Res; 1997 Jun; 25(11):2182-8. PubMed ID: 9153319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels.
    Postel EH; Flint SJ; Kessler DJ; Hogan ME
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8227-31. PubMed ID: 1896473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of transcription factor binding to the HER2 promoter by triplex-forming oligodeoxyribonucleotides.
    Noonberg SB; Scott GK; Hunt CA; Hogan ME; Benz CC
    Gene; 1994 Nov; 149(1):123-6. PubMed ID: 7958975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elements.
    Albert T; Wells J; Funk JO; Pullner A; Raschke EE; Stelzer G; Meisterernst M; Farnham PJ; Eick D
    J Biol Chem; 2001 Jun; 276(23):20482-90. PubMed ID: 11279041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cations on purine.purine.pyrimidine triple helix formation in mixed-valence salt solutions.
    Floris R; Scaggiante B; Manzini G; Quadrifoglio F; Xodo LE
    Eur J Biochem; 1999 Mar; 260(3):801-9. PubMed ID: 10103010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.